(19)
(11) EP 1 389 114 A2

(12)

(88) Date of publication A3:
24.07.2003

(43) Date of publication:
18.02.2004 Bulletin 2004/08

(21) Application number: 02750567.6

(22) Date of filing: 05.03.2002
(51) International Patent Classification (IPC)7A61K 31/54, A61K 31/415, A61P 9/10
// A61K31:54, A61K31:395, A61K31:415, A61K31:395
(86) International application number:
PCT/US2002/006570
(87) International publication number:
WO 2002/072104 (19.09.2002 Gazette 2002/38)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 08.03.2001 US 274288 P

(71) Applicant: Merck & Co., Inc.
Rahway,New Jersey 07065-0907 (US)

(72) Inventor:
  • NICHTBERGER, Steven, A.
    Rahway, NJ 07065-0907 (US)

(74) Representative: Buchan, Gavin MacNicol 
Merck & Co., Inc.,European Patent Department,Terlings Park,Eastwick Road
Harlow,Essex CM20 2QR
Harlow,Essex CM20 2QR (GB)

   


(54) ANTIHYPERTENSIVE AGENT AND CHOLESTEROL ABSORPTION INHIBITOR COMBINATION THERAPY